Cancer Clinical Trial Participation Found Unequal

Patients who speak English and live in less deprived areas are more likely to participate in trials.

Updated on Sept. 23, 2026 in Cancer

Isometric editorial illustration of a glass medical vial on a clean geometric platform, representing medical research accessibility. — A new study of nearly 98,000 California cancer patients reveals that clinical trial participation is significantly lower for non-English speakers and residents of more deprived neighborhoods. AI Illustration. Upload story photo >

Live Poll

Do you believe your local healthcare system provides equitable access to clinical trials for all patients?

A new study published in JAMA Network Open on September 17, 2026, analyzed data from 97,764 cancer patients in California to identify barriers to clinical trial enrollment. The findings reveal that trial participants were more likely to live in less deprived neighborhoods and speak English.

Why it matters

Identifying these disparities is crucial for ensuring that research findings are applicable to the diverse patient populations served in California. Understanding who participates helps health systems work toward more equitable access to innovative cancer therapies.

In a retrospective study of 97,764 patients treated between 2015 and 2022, researchers compared clinical trial enrollment across sociodemographic factors. The evidence suggests that trial participants were more likely to have stage IV disease and reside in less deprived areas.

The players

Kaiser Permanente Northern California

An integrated healthcare system that maintains a large cancer registry for residents of Northern California.

JAMA Network Open

A peer-reviewed medical journal that publishes original research on clinical topics and public health.

The details

Researchers utilized the Kaiser Permanente Northern California cancer registry to track patient demographics and trial participation over seven years. The study identified that patients who speak English as a primary language are better represented in clinical trials than non-English speakers. Participants were also consistently more likely to be living in areas with lower socioeconomic deprivation scores.

January 1, 2015 to December 31, 2022: Study period for data collection.
September 17, 2026: Publication of findings in JAMA Network Open.

Health Landscape

This study follows a pattern of research identifying significant barriers to equitable participation in clinical trials. It highlights how factors beyond clinical stage, such as neighborhood stability and language, continue to influence who gains access to experimental treatments.

If you are managing a cancer diagnosis, it is worth asking your physician if a clinical trial is an appropriate treatment option for you. You may also want to discuss what language support services or transportation resources are available to help you access care at a research site.

The takeaway

Clinical trial participation remains influenced by socioeconomic factors, meaning not all patients are equally represented in research. Patients are encouraged to have open conversations with their oncology team about whether a trial might be a suitable path for their specific diagnosis.